Deb G - Search Results

1

Spindle cell (Kaposiform) hemangioendothelioma with Kasabach-Merritt syndrome in an infant: successful treatment with alpha-2A interferon.

Deb G, Jenkner A, De Sio L, Boldrini R, Bosman C, Standoli N, Donfrancesco A. Deb G, et al. Med Pediatr Oncol. 1997 May;28(5):358-61. doi: 10.1002/(sici)1096-911x(199705)28:5<358::aid-mpo6>3.0.co;2-g. Med Pediatr Oncol. 1997. PMID: 9121401

2

Hemangioendothelioma: successful therapy with interferon-alpha: a study in Association with the Italian Pediatric Haematology/Oncology Society (AIEOP).

Deb G, Donfrancesco A, Ilari I, De Sio L, Milano GM, Ghitti C, Fontana G, Sandri A, Helson L. Deb G, et al. Med Pediatr Oncol. 2002 Feb;38(2):118-9. doi: 10.1002/mpo.1284. Med Pediatr Oncol. 2002. PMID: 11813178 Clinical Trial. No abstract available.

3

Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECaT): a new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastoma.

Donfrancesco A, Deb G, Dominici C, Angioni A, Caniglia M, De Sio L, Fidani P, Amici A, Helson L. Donfrancesco A, et al. Among authors: deb g. Am J Clin Oncol. 1992 Aug;15(4):319-22. doi: 10.1097/00000421-199208000-00009. Am J Clin Oncol. 1992. PMID: 1514528

4

Role of deferoxamine in tumor therapy.

Donfrancesco A, Deb G, De Sio L, Cozza R, Castellano A. Donfrancesco A, et al. Among authors: deb g. Acta Haematol. 1996;95(1):66-9. doi: 10.1159/000203951. Acta Haematol. 1996. PMID: 8604589 Review.

5

High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors.

Castello MA, Clerico A, Deb G, Dominici C, Fidani P, Donfrancesco A. Castello MA, et al. Among authors: deb g. Am J Pediatr Hematol Oncol. 1990 Fall;12(3):297-300. doi: 10.1097/00043426-199023000-00008. Am J Pediatr Hematol Oncol. 1990. PMID: 2173440

6

Effects of a single course of deferoxamine in neuroblastoma patients.

Donfrancesco A, Deb G, Dominici C, Pileggi D, Castello MA, Helson L. Donfrancesco A, et al. Among authors: deb g. Cancer Res. 1990 Aug 15;50(16):4929-30. Cancer Res. 1990. PMID: 2379156

7

D-CECaT: a breakthrough for patients with neuroblastoma.

Donfrancesco A, Deb G, Angioni A, Maurizio C, Cozza R, Jenkner A, Landolfo A, Boglino C, Helson L. Donfrancesco A, et al. Among authors: deb g. Anticancer Drugs. 1993 Jun;4(3):317-21. Anticancer Drugs. 1993. PMID: 8395258 Clinical Trial.

8

D-CECaT as preoperative chemotherapy for unresectable neuroblastoma in children over one year of age.

Donfrancesco A, Deb G, Dominici C, De Sio L, Inserra A, Boglino C, Takahashi M, Uchino J, Helson L. Donfrancesco A, et al. Among authors: deb g. Anticancer Res. 1995 Sep-Oct;15(5B):2347-50. Anticancer Res. 1995. PMID: 8572650

9

Sporadic acute lymphocytic leukemia arising in a patient with neurofibromatosis and xanthogranulomatosis.

Deb G, Habetswallner D, Helson L, De Sio L, Caniglia M, Donfrancesco A. Deb G, et al. Cancer Invest. 1996;14(2):109-11. doi: 10.3109/07357909609018885. Cancer Invest. 1996. PMID: 8597895

10

Spastic diplegia and interferon.

Deb G, Jenkner A, Donfrancesco A. Deb G, et al. J Pediatr. 1999 Mar;134(3):382. doi: 10.1016/s0022-3476(99)70474-9. J Pediatr. 1999. PMID: 10064684 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

65 results

Search Page